216 related articles for article (PubMed ID: 21910250)
1. DNA methylation profiling reveals a predominant immune component in breast cancers.
Dedeurwaerder S; Desmedt C; Calonne E; Singhal SK; Haibe-Kains B; Defrance M; Michiels S; Volkmar M; Deplus R; Luciani J; Lallemand F; Larsimont D; Toussaint J; Haussy S; Rothé F; Rouas G; Metzger O; Majjaj S; Saini K; Putmans P; Hames G; van Baren N; Coulie PG; Piccart M; Sotiriou C; Fuks F
EMBO Mol Med; 2011 Dec; 3(12):726-41. PubMed ID: 21910250
[TBL] [Abstract][Full Text] [Related]
2. DNA methylation-based immune response signature improves patient diagnosis in multiple cancers.
Jeschke J; Bizet M; Desmedt C; Calonne E; Dedeurwaerder S; Garaud S; Koch A; Larsimont D; Salgado R; Van den Eynden G; Willard Gallo K; Bontempi G; Defrance M; Sotiriou C; Fuks F
J Clin Invest; 2017 Aug; 127(8):3090-3102. PubMed ID: 28714863
[TBL] [Abstract][Full Text] [Related]
3. Regulation of DNA methylation patterns by CK2-mediated phosphorylation of Dnmt3a.
Deplus R; Blanchon L; Rajavelu A; Boukaba A; Defrance M; Luciani J; Rothé F; Dedeurwaerder S; Denis H; Brinkman AB; Simmer F; Müller F; Bertin B; Berdasco M; Putmans P; Calonne E; Litchfield DW; de Launoit Y; Jurkowski TP; Stunnenberg HG; Bock C; Sotiriou C; Fraga MF; Esteller M; Jeltsch A; Fuks F
Cell Rep; 2014 Aug; 8(3):743-53. PubMed ID: 25066127
[TBL] [Abstract][Full Text] [Related]
4. TET2 and TET3 regulate GlcNAcylation and H3K4 methylation through OGT and SET1/COMPASS.
Deplus R; Delatte B; Schwinn MK; Defrance M; Méndez J; Murphy N; Dawson MA; Volkmar M; Putmans P; Calonne E; Shih AH; Levine RL; Bernard O; Mercher T; Solary E; Urh M; Daniels DL; Fuks F
EMBO J; 2013 Mar; 32(5):645-55. PubMed ID: 23353889
[TBL] [Abstract][Full Text] [Related]
5. Down-regulation of ECRG4, a candidate tumor suppressor gene, in human breast cancer.
Sabatier R; Finetti P; Adelaide J; Guille A; Borg JP; Chaffanet M; Lane L; Birnbaum D; Bertucci F
PLoS One; 2011; 6(11):e27656. PubMed ID: 22110708
[TBL] [Abstract][Full Text] [Related]
6. Correlating transcriptional networks to breast cancer survival: a large-scale coexpression analysis.
Clarke C; Madden SF; Doolan P; Aherne ST; Joyce H; O'Driscoll L; Gallagher WM; Hennessy BT; Moriarty M; Crown J; Kennedy S; Clynes M
Carcinogenesis; 2013 Oct; 34(10):2300-8. PubMed ID: 23740839
[TBL] [Abstract][Full Text] [Related]
7. SOX2 controls tumour initiation and cancer stem-cell functions in squamous-cell carcinoma.
Boumahdi S; Driessens G; Lapouge G; Rorive S; Nassar D; Le Mercier M; Delatte B; Caauwe A; Lenglez S; Nkusi E; Brohée S; Salmon I; Dubois C; del Marmol V; Fuks F; Beck B; Blanpain C
Nature; 2014 Jul; 511(7508):246-50. PubMed ID: 24909994
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the Infinium Methylation 450K technology.
Dedeurwaerder S; Defrance M; Calonne E; Denis H; Sotiriou C; Fuks F
Epigenomics; 2011 Dec; 3(6):771-84. PubMed ID: 22126295
[TBL] [Abstract][Full Text] [Related]
9. RNA biochemistry. Transcriptome-wide distribution and function of RNA hydroxymethylcytosine.
Delatte B; Wang F; Ngoc LV; Collignon E; Bonvin E; Deplus R; Calonne E; Hassabi B; Putmans P; Awe S; Wetzel C; Kreher J; Soin R; Creppe C; Limbach PA; Gueydan C; Kruys V; Brehm A; Minakhina S; Defrance M; Steward R; Fuks F
Science; 2016 Jan; 351(6270):282-5. PubMed ID: 26816380
[TBL] [Abstract][Full Text] [Related]
10. Sox9 Controls Self-Renewal of Oncogene Targeted Cells and Links Tumor Initiation and Invasion.
Larsimont JC; Youssef KK; Sánchez-Danés A; Sukumaran V; Defrance M; Delatte B; Liagre M; Baatsen P; Marine JC; Lippens S; Guerin C; Del Marmol V; Vanderwinden JM; Fuks F; Blanpain C
Cell Stem Cell; 2015 Jul; 17(1):60-73. PubMed ID: 26095047
[TBL] [Abstract][Full Text] [Related]
11. DNA methylation profiling identifies epigenetic dysregulation in pancreatic islets from type 2 diabetic patients.
Volkmar M; Dedeurwaerder S; Cunha DA; Ndlovu MN; Defrance M; Deplus R; Calonne E; Volkmar U; Igoillo-Esteve M; Naamane N; Del Guerra S; Masini M; Bugliani M; Marchetti P; Cnop M; Eizirik DL; Fuks F
EMBO J; 2012 Mar; 31(6):1405-26. PubMed ID: 22293752
[TBL] [Abstract][Full Text] [Related]
12. DNA methylome profiling beyond promoters - taking an epigenetic snapshot of the breast tumor microenvironment.
Jeschke J; Collignon E; Fuks F
FEBS J; 2015 May; 282(9):1801-14. PubMed ID: 25331982
[TBL] [Abstract][Full Text] [Related]
13. A comprehensive overview of Infinium HumanMethylation450 data processing.
Dedeurwaerder S; Defrance M; Bizet M; Calonne E; Bontempi G; Fuks F
Brief Bioinform; 2014 Nov; 15(6):929-41. PubMed ID: 23990268
[TBL] [Abstract][Full Text] [Related]
14. ROCK: a resource for integrative breast cancer data analysis.
Ur-Rehman S; Gao Q; Mitsopoulos C; Zvelebil M
Breast Cancer Res Treat; 2013 Jun; 139(3):907-21. PubMed ID: 23756628
[TBL] [Abstract][Full Text] [Related]
15. An evaluation of analysis pipelines for DNA methylation profiling using the Illumina HumanMethylation450 BeadChip platform.
Marabita F; Almgren M; Lindholm ME; Ruhrmann S; Fagerström-Billai F; Jagodic M; Sundberg CJ; Ekström TJ; Teschendorff AE; Tegnér J; Gomez-Cabrero D
Epigenetics; 2013 Mar; 8(3):333-46. PubMed ID: 23422812
[TBL] [Abstract][Full Text] [Related]
16. A three-gene model to robustly identify breast cancer molecular subtypes.
Haibe-Kains B; Desmedt C; Loi S; Culhane AC; Bontempi G; Quackenbush J; Sotiriou C
J Natl Cancer Inst; 2012 Feb; 104(4):311-25. PubMed ID: 22262870
[TBL] [Abstract][Full Text] [Related]
17. The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups.
Curtis C; Shah SP; Chin SF; Turashvili G; Rueda OM; Dunning MJ; Speed D; Lynch AG; Samarajiwa S; Yuan Y; Gräf S; Ha G; Haffari G; Bashashati A; Russell R; McKinney S; ; Langerød A; Green A; Provenzano E; Wishart G; Pinder S; Watson P; Markowetz F; Murphy L; Ellis I; Purushotham A; Børresen-Dale AL; Brenton JD; Tavaré S; Caldas C; Aparicio S
Nature; 2012 Apr; 486(7403):346-52. PubMed ID: 22522925
[TBL] [Abstract][Full Text] [Related]
18. Concurrent gene signatures for han chinese breast cancers.
Huang CC; Tu SH; Lien HH; Jeng JY; Huang CS; Huang CJ; Lai LC; Chuang EY
PLoS One; 2013; 8(10):e76421. PubMed ID: 24098497
[TBL] [Abstract][Full Text] [Related]
19. Immunity drives
Collignon E; Canale A; Al Wardi C; Bizet M; Calonne E; Dedeurwaerder S; Garaud S; Naveaux C; Barham W; Wilson A; Bouchat S; Hubert P; Van Lint C; Yull F; Sotiriou C; Willard-Gallo K; Noel A; Fuks F
Sci Adv; 2018 Jun; 4(6):eaap7309. PubMed ID: 29938218
[TBL] [Abstract][Full Text] [Related]
20. Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response.
Jiang P; Gu S; Pan D; Fu J; Sahu A; Hu X; Li Z; Traugh N; Bu X; Li B; Liu J; Freeman GJ; Brown MA; Wucherpfennig KW; Liu XS
Nat Med; 2018 Oct; 24(10):1550-1558. PubMed ID: 30127393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
